Search Page

1

Cite

Share

Neuroprotective and anti-ageing role of leptin.

Folch J, Pedrós I, Patraca I, Sureda F, Junyent F, Beas-Zarate C, Verdaguer E, Pallàs M, Auladell C, Camins A. Folch J, et al. Among authors: junyent f. J Mol Endocrinol. 2012 Oct 10;49(3):R149-56. doi: 10.1530/JME-12-0151. Print 2012 Dec. J Mol Endocrinol. 2012. PMID: 22967480 Review.

Cite

Share

2

Cite

Share

CAV-2--why a canine virus is a neurobiologist's best friend.

Junyent F, Kremer EJ. Junyent F, et al. Curr Opin Pharmacol. 2015 Oct;24:86-93. doi: 10.1016/j.coph.2015.08.004. Epub 2015 Aug 25. Curr Opin Pharmacol. 2015. PMID: 26298516 Review.

Cite

Share

3

Cite

Share

Aging biology: a new frontier for drug discovery.

Verdaguer E, Junyent F, Folch J, Beas-Zarate C, Auladell C, Pallàs M, Camins A. Verdaguer E, et al. Among authors: junyent f. Expert Opin Drug Discov. 2012 Mar;7(3):217-29. doi: 10.1517/17460441.2012.660144. Epub 2012 Feb 2. Expert Opin Drug Discov. 2012. PMID: 22468953 Review.

Cite

Share

4

Cite

Share

Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus.

Gulfo J, Pérez de San Román J, Ledda A, Junyent F, Ramírez MJ, Gil-Bea FJ, Esteve M, Grasa M. Gulfo J, et al. Among authors: junyent f. PLoS One. 2021 Feb 16;16(2):e0246930. doi: 10.1371/journal.pone.0246930. eCollection 2021. PLoS One. 2021. PMID: 33592009 Free PMC article.

Cite

Share

5

Cite

Share

Sirtuin activators: designing molecules to extend life span.

Camins A, Sureda FX, Junyent F, Verdaguer E, Folch J, Pelegri C, Vilaplana J, Beas-Zarate C, Pallàs M. Camins A, et al. Among authors: junyent f. Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):740-9. doi: 10.1016/j.bbagrm.2010.06.005. Epub 2010 Jun 23. Biochim Biophys Acta. 2010. PMID: 20601277 Review.

Cite

Share

6

Cite

Share

Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases.

Sureda FX, Junyent F, Verdaguer E, Auladell C, Pelegri C, Vilaplana J, Folch J, Canudas AM, Zarate CB, Pallès M, Camins A. Sureda FX, et al. Among authors: junyent f. Curr Pharm Des. 2011;17(3):230-45. doi: 10.2174/138161211795049732. Curr Pharm Des. 2011. PMID: 21348832 Review.

Cite

Share

7

Cite

Share

Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium.

Camins A, Verdaguer E, Junyent F, Yeste-Velasco M, Pelegrí C, Vilaplana J, Pallás M. Camins A, et al. Among authors: junyent f. CNS Neurosci Ther. 2009 Winter;15(4):333-44. doi: 10.1111/j.1755-5949.2009.00086.x. CNS Neurosci Ther. 2009. PMID: 19889130 Free PMC article. Review.

Cite

Share

8

Cite

Share

An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders.

Camins A, Sureda FX, Junyent F, Verdaguer E, Folch J, Beas-Zarate C, Pallas M. Camins A, et al. Among authors: junyent f. Expert Opin Investig Drugs. 2010 May;19(5):587-604. doi: 10.1517/13543781003781898. Expert Opin Investig Drugs. 2010. PMID: 20402598 Review.

Cite

Share

9

Cite

Share

Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death.

Folch J, Junyent F, Verdaguer E, Auladell C, Pizarro JG, Beas-Zarate C, Pallàs M, Camins A. Folch J, et al. Among authors: junyent f. Neurotox Res. 2012 Oct;22(3):195-207. doi: 10.1007/s12640-011-9277-4. Epub 2011 Oct 1. Neurotox Res. 2012. PMID: 21965004 Review.

Cite

Share

10

Cite

Share

Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases.

Camins A, Junyent F, Verdaguer E, Beas-Zarate C, Rojas-Mayorquín AE, Ortuño-Sahagún D, Pallàs M. Camins A, et al. Among authors: junyent f. Pharmaceuticals (Basel). 2009 Dec 15;2(3):194-205. doi: 10.3390/ph2030194. Pharmaceuticals (Basel). 2009. PMID: 27713233 Free PMC article. Review.

Cite

Share